tiprankstipranks
A New Cause for Concern: Theravance Biopharma Adds a New Costs Risk
PremiumCompany AnnouncementsA New Cause for Concern: Theravance Biopharma Adds a New Costs Risk
4M ago
Short Report: Bears cut down exposure to crypto names as bitcoin price spikes
PremiumThe Fly
Short Report: Bears cut down exposure to crypto names as bitcoin price spikes
4M ago
Theravance Biopharma reports Q4 EPS (17c), consensus (15c)
PremiumThe Fly
Theravance Biopharma reports Q4 EPS (17c), consensus (15c)
4M ago
Viatris, Theravance announce top-line results from YUPELRI Phase III trial
PremiumThe FlyViatris, Theravance announce top-line results from YUPELRI Phase III trial
8M ago
Viatris, Theravance Biopharma announce results from YUPELRI
PremiumThe Fly
Viatris, Theravance Biopharma announce results from YUPELRI
8M ago
Theravance Biopharma reports Q3 EPS (17c), consensus (21c)
PremiumThe Fly
Theravance Biopharma reports Q3 EPS (17c), consensus (21c)
8M ago
Theravance Biopharma reports Q2 EPS (28c), consensus (21c)
PremiumThe FlyTheravance Biopharma reports Q2 EPS (28c), consensus (21c)
11M ago
Theravance Biopharma (TBPH) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Theravance Biopharma (TBPH) Q2 Earnings Cheat Sheet
11M ago
TBPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
TBPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100